Drug Topics
AUGUST 26, 2024
“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.
Pharmacy Is Right For Me
AUGUST 26, 2024
What is your first thought when you think of a career in pharmacy? You may think of a clinical pharmacist working in a community pharmacy or a hospital pharmacist working in an in-patient unit. But did you think about pharmacogenomics: the field of pharmacy that studies how someone’s genetics affect their response to a certain drug? Not many people are aware of the field of pharmacogenomics, and how it can optimize patient outcomes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 26, 2024
The Stelo glucose biosensor system is intended for use in adults who do not use insulin or in those without diabetes who wish to better understand how diet and exercise affect blood glucose levels.
Pharmacy Times
AUGUST 26, 2024
Aligning with previous data, the drug combination was modestly effective in patients with large B-cell lymphoma pre- and post-CAR-T-cell therapy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
AUGUST 26, 2024
Don’t miss out on the latest pharmacy insights in the Total Pharmacy June issue.
PharmaVoice
AUGUST 26, 2024
Despite the disappointing results, the drug’s developer, Siga Therapeutics, said there’s more to the story.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
AUGUST 26, 2024
Recently, Columbia University’s president resigned after months of chaos, following in the footsteps of Harvard and my own institution, Penn. Besides struggling with encampments, building takeovers, and commencement challenges, the three universities have something else in common: They have all chosen M.D.s as president or interim president.
Drug Topics
AUGUST 26, 2024
Check out these featured Drug Topics interviews from August 2024.
Pharmacy Times
AUGUST 26, 2024
Pharmacists can be essential sources of education for patients, offering them guidance on safe use and proper dosage.
STAT
AUGUST 26, 2024
NEW YORK — Glucose tracking is the future, Dexcom executives gushed at a glitzy launch event for their new, over-the-counter continuous glucose monitor on Wednesday evening. Surrounded by champagne, new celebrity ambassador and “Parks and Rec” actress Retta, and a mini-pickleball court, CEO Kevin Sayer declared victory. “Dexcom has literally created an industry, and now it’s time to create a much broader revolution in health care,” Sayer told
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
AUGUST 26, 2024
Electronic health records giant Epic recently announced plans to transition its customers to a new government-backed data exchange by the end of next year. | Carequality and Epic both revealed plans to align with TEFCA, signaling potentially a "tectonic shift" in the interoperability landscape and the rising influence of the federal government's nascent network, health IT experts say.
STAT
AUGUST 26, 2024
Once a year, Jessi Keavney goes to see her neurologist. During the visit, the doctor asks if she has developed any new symptoms and then performs a detailed physical exam. He observes the speed and amplitude of her hand and foot movements, and then assesses her ability to stand from a seated position. While she walks, the doctor evaluates her arm swing, the length of her stride, and her posture.
PharmaVoice
AUGUST 26, 2024
The final drug prices for Medicare’s negotiation program have been published, but pharma companies continue to push their legal strategies.
STAT
AUGUST 26, 2024
The U.N. health agency on Monday launched a six-month plan to help stanch outbreaks of mpox transmission, including ramping up staffing in affected countries and boosting surveillance, prevention and response strategies. The World Health Organization said it expects the plan from September through February next year will require $135 million in funding and aims to improve fair access to vaccines, notably in African countries hardest hit by the outbreak.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
AUGUST 26, 2024
A major drugmaker’s plan to trade out upfront 340B discounts for rebates has found swift pushback from both hospitals participating in the drug subsidy program and the government administration tha | The drugmaker said it plans to require DSH covered entities obtain their drug discounts by submitting for a rebate after dispensing. That approach would add financial and liquidity strain to safety-net hospitals and goes against 340B statute, per a hospital industry group statement that was echoed b
STAT
AUGUST 26, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. And hello again! Miss us?
Fierce Healthcare
AUGUST 26, 2024
A new specialty pharmacy program by digital health company Waltz Health has been created to lower costs for payers and provide better experiences for patients and pharmacies. | Waltz Connect will use its AI engine to route specialty drug prescriptions to the most ideal location for payers and patients based on weighted attributes. The company is also partnering with Reliance Rx.
STAT
AUGUST 26, 2024
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Happy Eldest Daughter Day. I am not the first daughter in my family, but I was always the oldest sibling in the house while growing up. I’m often willing to indulge in a discussion of that burden, but I saw the movie “Dìdi” this weekend.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
AUGUST 26, 2024
A US government agency has hit back at a plan by Johnson & Johnson to change the way it pays discounts on drugs to hospitals in the controversial 340B programme
Fierce Healthcare
AUGUST 26, 2024
Aetna will now cover intrauterine insemination (IUI) as a benefit in eligible plans nationwide, becoming the first major insurer to expand coverage nationally. | Aetna will now cover intrauterine insemination as a benefit in eligible plans nationwide, becoming the first major insurer to expand coverage nationally.
STAT
AUGUST 26, 2024
Happy Monday, Pharmalittle family. Adam Feuerstein here, once again filling in for Ed. I have been assured that Ed is staying caffeinated, even in his absence. Let’s take a look at some morning news. … Belgian drugmaker UCB is selling its Chinese neurology and allergy business to Singapore-based asset management group CBC and Abu Dhabi sovereign investor Mubadala for $680 million , Reuters tells us.
Pharmacy Times
AUGUST 26, 2024
In Finland, season of birth, notably autumn and winter, was associated with the development of asthma and allergic rhinitis.
Fierce Healthcare
AUGUST 26, 2024
In this week's episode of "Podnosis," we dive into a discussion with two founders of the | In this week's episode of "Podnosis," we dive into a discussion with two founders of the Coalition for Health AI about why both local providers and the federal government must play a role in overseeing AI in healthcare.
The Checkup by Singlecare
AUGUST 26, 2024
Gabapentin (brand name Neurontin ) is an anti-seizure medication that is primarily used to alleviate nerve pain and manage seizures. The prescription drug is FDA approved to control seizures in adults and children with epilepsy and treat a type of nerve pain called postherpetic neuralgia (PHN) that can occur after a shingles infection. It’s also used off-label to treat diabetic neuropathy, fibromyalgia, neuropathic pain from sciatica, alcohol dependence, and anxiety.
The FDA Law Blog
AUGUST 26, 2024
By Larry K. Houck — Who says nothing happens in Washington, D.C., in August? The Drug Enforcement Administration (“DEA”) will announce Thursday in the Federal Register that it will hold a hearing on the proposed rescheduling of marijuana to schedule III at DEA Headquarters in Arlington, Virginia on December 2, 2024. DEA received over 43,500 public comments in response to the agency’s Notice of Proposed Rulemaking in the Federal Register on May 21, 2024.
Fierce Pharma
AUGUST 26, 2024
Restructuring seems to be the name of the game for many large drugmakers these days, and Belgium-based UCB is no except | Belgium’s UCB is selling off its mature neurology and allergy business—plus a manufacturing plant—in mainland China. The deal will see local healthcare asset manager CBC Group and Abu Dhabi-based investment firm Mubadala pay UCB $680 million.
Pharmacy Times
AUGUST 26, 2024
Pediatric patients weighing 20 kg to <50 kg should take 20 mg of apremilast twice daily and children weighing at least 50 kg should take 30 mg twice daily.
pharmaphorum
AUGUST 26, 2024
Changing Faces – Agency, consultancy, and investor hires from July 2024: Stay updated on the latest hires at EVERSANA, Ogilvy Health, Skarbek, and more in the industry.
Pharmacy Times
AUGUST 26, 2024
The proposed diagnostic agent has a long half-life, enables imaging the next day, and correlates to a longer shelf life in the pharmacy.
pharmaphorum
AUGUST 26, 2024
Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment Mike.
Pharmacy Times
AUGUST 26, 2024
Let’s shine the spotlight on ourselves, and let’s begin to heal.
Fierce Pharma
AUGUST 26, 2024
Even as Johnson & Johnson prepares to weather the impact of negotiated Medicare drug prices on two of its | The new rebate model would require eligible hospitals to submit rebate claims after paying full price for the drugs, as opposed to upfront discounts.
Pharmacy Times
AUGUST 26, 2024
Building trust between techs and patients makes administering vaccines easier and increase immunizers’ confidence.
Expert insights. Personalized for you.
421 
Let's personalize your content